StockData
Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc. (INSP) stock

INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 17/3032% below fair value
$68.10−3.08 (-4.33%)

Close on Oct 30, 2026Market cap $1.97BP/E 14.7Yield –

Earnings

Inspire Medical Systems's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 2, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$200.60M
-7.6% on a year earlier
adjusted diluted EPS, Q2 FY2026
$0.14
$0.45 a year earlier
Latest guidance
Raised
Aug 3, 2026 · 8 items

Quarterly results

Revenue and earnings per share from each of Inspire Medical Systems's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2026ended Sep 30, 2026Nov 2, 2026Expected–––––
Q2 FY2026ended Jun 30, 2026Aug 3, 2026after the close$200.60M-7.6%$0.01$0.14Release
Q1 FY2026ended Mar 31, 2026May 4, 2026after the close$204.60M+1.6%-$0.39$0.10Release
Q4 FY2025ended Dec 31, 2025Jan 12, 2026after the close––––Release
Q3 FY2025ended Sep 30, 2025Nov 3, 2025after the close$224.50M+10.5%$0.34$0.38Release
Q2 FY2025ended Jun 30, 2025Aug 4, 2025after the close$217.10M+10.8%-$0.12$0.45Release
Q1 FY2025ended Mar 31, 2025May 5, 2025after the close$201.30M+22.7%$0.10–Release
Q4 FY2024ended Dec 31, 2024Jan 13, 2025before the open––––Release
Q3 FY2024ended Sep 30, 2024Nov 4, 2024after the close$203.20M+32.6%$0.60–Release
Q2 FY2024ended Jun 30, 2024Jul 29, 2024before the open$195.90M+29.6%––Release
Q1 FY2024ended Mar 31, 2024May 7, 2024after the close$164.00M+28.2%-$0.34–Release
Q4 FY2023ended Dec 31, 2023Jan 8, 2024before the open––––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Inspire Medical Systems's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueFY2026$835.00M – $875.00M$825.00M – $875.00MRaisedAug 3, 2026
annual adjusted operating marginnon-GAAPFY20264% – 6%2% – 4%RaisedAug 3, 2026
diluted EPSGAAPFY2026-$0.42 – $0.17$0.07 – $0.62LoweredAug 3, 2026
adjusted diluted EPSnon-GAAPFY2026$1.05 – $1.45$0.75 – $1.25RaisedAug 3, 2026
capital expendituresFY2026$35.00M – $40.00M$40.00M – $45.00MLoweredAug 3, 2026
adjusted effective tax ratenon-GAAPFY202630% – 35%27% – 29%RaisedAug 3, 2026
effective tax rateGAAPFY202695% – 100%65% – 70%RaisedAug 3, 2026
estimated weighted average diluted shares outstandingFY202629.429.4ReaffirmedAug 3, 2026

Guidance history

Every forecast Inspire Medical Systems put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 3, 2026capital expendituresFY2026$35.00M – $40.00MLowered
Aug 3, 2026adjusted diluted EPSFY2026$1.05 – $1.45Raised
Aug 3, 2026diluted EPSFY2026-$0.42 – $0.17Lowered
Aug 3, 2026annual adjusted operating marginFY20264% – 6%Raised
Aug 3, 2026estimated weighted average diluted shares outstandingFY202629.4Reaffirmed
Aug 3, 2026effective tax rateFY202695% – 100%Raised
Aug 3, 2026adjusted effective tax rateFY202630% – 35%Raised
Aug 3, 2026revenueFY2026$835.00M – $875.00MRaised
May 4, 2026capital expendituresFY2026$40.00M – $45.00MNew
May 4, 2026adjusted diluted EPSFY2026$0.75 – $1.25New
May 4, 2026diluted EPSFY2026$0.07 – $0.62New
May 4, 2026adjusted operating marginFY20262% – 4%New
May 4, 2026estimated weighted average diluted shares outstandingFY202629.4New
May 4, 2026effective tax rateFY202665% – 70%New
May 4, 2026adjusted effective tax rateFY202627% – 29%New
May 4, 2026revenueFY2026$825.00M – $875.00MLowered
Jan 12, 2026RevenueFY2026$1.00B – $1.01BNew
Nov 3, 2025diluted net income per share guidanceFY2025$0.90 – $1.00New
Nov 3, 2025gross margin guidanceFY202584% – 86%New
Nov 3, 2025revenue growthFY2025+12% – +13%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Inspire Medical Systems filed with the SEC as exhibits to Form 8-K or 6-K

  1. Inspire Medical Systems, Inc. Announces Second Quarter 2026
    Results
  2. Inspire Medical Systems, Inc. August 2026 NYSE: INSP
    Results
  3. Inspire Medical Systems, Inc. Announces First Quarter 2026
    Results
  4. Inspire Medical Systems, Inc. May 2026 NYSE: INSP
    Results
  5. Inspire Medical Systems, Inc. Announces Fourth Quarter and
    Results
  6. Inspire Medical Systems, Inc. February 2026 NYSE: INSP
    Results
  7. Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
    Results
  8. Inspire Medical Systems, Inc. JP Morgan Healthcare Conference January 12, 2026 NYSE: INSP
    Results
  9. Inspire Medical Systems, Inc. Announces Third Quarter 2025
    Results
  10. Inspire Medical Systems, Inc. November 2025 NYSE: INSP
    Results
  11. Inspire Medical Systems, Inc. Publishes Inspire V Data at
    Update
  12. 8-K exhibit EX-99.2
    Update
  13. Inspire Medical Systems, Inc. Announces Departure of
    Update
  14. 8-K exhibit EX-99.1
    News
  15. Inspire Medical Systems, Inc. Announces Second Quarter 2025
    Results